A spinal cord stimulator (SCS), also termed as a dorsal column stimulator, it is a device which is surgically placed beneath the skin near the gluteal area in order to send a mild electric current to your spinal cord through an electric pulse generator. This device contains stimulating electrodes which is planted within the epidural space. Small thin wires carry the current from the pulse generator to the nerve fibers of the spinal cord. Once the device is switched on, the stimulation that it emits feels like a mild tingling in the pain area. Spinal cord stimulator works on the pain management therapy, while it does not obviate the source that is responsible for the chronic pain; instead, the stimulators hamper the pain signals’ transmission that reaches the brain. Therefore, the brain in unable to recognize the pain, and a few patients feel the tingling sensation to be very disturbing. Hence, trial stimulation is carried out prior to the device getting fixed permanently. SCS device renders positive and diagnostic effect in case of Failed Back Surgery Syndrome (FBSS), cervical radiculopathy, sciatica, Arachnoiditis and Peripheral Neuropathy and Reflex sympathetic dystrophy.
Top Manufacturers Analysis of Spinal Cord Stimulator:-
Direct Spinal Therapeutics, Inc., G-Therapeutics SA Company, Imperial College London Company, Meagan Medical Inc., Medtrode Inc..
Browse Complete Report At: http://www.qyresearchgroups.com/report/global-spinal-cord-stimulator-market-research-report-2016
In the United States, the FDA approved Spinal cord stimulation in 1989, so as to alleviate pain from nerve damage in the arms and legs. Presently, spinal cord stimulators are accountable for more than 70% of the global neuromodulation treatments. The Global Spinal Cord Stimulator Market is anticipated to have a lucrative growth with a higher CAGR during the forecast period. The SCS market is huge and continues to comparatively remain untouched even though it proves to have a great potential to treat chronic back pain. Increasing geriatric population, escalated demand of minimally invasive surgeries, and mounting age-old demographics are all factors which are driving this industry’s market to a positive growth. However, the stimulation sometimes fail to show any effect on certain patients depending upon the condition; in such cases the implant needs to be removed without damaging the spinal cord nerves. Besides, the market drivers, there exists a few market hindrances such as unpleasant reimbursement situation, shortage of trained professional and less cost efficiency linked with the therapy.
To Request Sample Copy Of This Report: http://www.qyresearchgroups.com/request-sample/149340
According to the estimation by AANS’s, approximately fifty thousand SCS are planted each year on a global level. This number is predicted to increase considerably to manage chronic disease states as the elderly populations keeps increasing. Various pain management societies are proactively increasing and spreading awareness about SCS devices via international conferences, seminars, workshops, and annual meets. A few major industry players of global spinal cord stimulator market are Meagan Medical Inc., Medtrode Inc., NeuroRecovery Technologies Inc., G-Therapeutics SA Company, Imperial College London Company, MicroTransponder Inc., St. Jude Medical, Inc., Direct Spinal Therapeutics, Inc., Saluda Medical Pty Ltd, and PathMaker Neurosystems Inc Company.
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China